Abstract
Aims/hypothesisDyslipidemia is an important modifiable risk factor and lipid-lowering treatment (LLT) is essential to reduce the risk of cardiovascular disease (CVD). Studies in type 2 diabetes indicate that low adherence...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have